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ABSTRACT 
 Flaviviruses are positive-strand single-stranded RNA viruses that are known to 
form pseudo-knot RNA structures that halt the progression of 5’3’ exonuclease Xrn1. 
We show that these viral Xrn1-resistant structures (xrRNAs) can be used to protect 
specific homologously-expressed messenger RNAs from 5’3’ degradation. We 
investigated the effects of addition of xrRNAs, artificially-installed into the intergenic 
region of bicistronic mRNA reporters, in the observed levels of protein expression in 
yeast. The reporters also contain an internal ribosome entry site from the cricket paralysis 
virus (CrPV IRES) to allow for cap-independent translation of the decay-protected gene, 
LacZ, encoding the enzyme β-galactosidase. Through the use of primer extension, β-
galactosidase assay, and western blots, the results indicate that the partially-decayed 
RNAs are successfully translated, and that addition of xrRNAs results in a 30-50 fold 
increase in measured enzymatic activity and an accumulation of decay-resistant 
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CHAPTER ONE: INTRODUCTION 
 
1.1       Eukaryotic mRNA  
The central dogma of molecular biology paints a simple picture of the flow of 
genetic information in the cell: DNA is used as a blueprint to make messenger RNA 
(mRNA), which in turn gets translated into protein. In reality, the transfer of genetic 
information follows a dynamic system in which the flow of information is heavily 
regulated in a bilateral fashion (Vihervaara et al., 2008). Cells have evolved complex and 
precise regulatory systems to alter the rate of gene expression in response to internal or 
external stimuli with the use of enzymes and regulatory molecules. An important aspect 
of gene expression is the regulation of mRNA levels in the cell, which is highly 
dependent on the rate of two opposing processes: transcription and decay (Alonso, 2012). 
Decay of mRNA transcripts can occur via different redundant pathways in yeast 
(Parker, 2012). In the 5’3’ direction, the major exonuclease responsible for mRNA 
decay is the enzyme XRN1, which recognizes a 5’ monophosphate left behind after the 5’ 
cap is removed by a decapping enzyme (Geerlings et al., 2000). Viral pseudoknot RNA 
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structures known as xrRNAs have been shown to resist decay by XRN1 by presenting the 
enzyme with a mechanical barrier. These XRN1-resistant structures are known to protect 
fragments of the viral genome from degradation, resulting in the accumulation of decay-
resistant fragments that have been linked to increased pathogenicity in the infected cells 
(Chapman et al., 2014a, 2014b, Akiyama et al., 2016). By studying these decay-resistant 
structures, it may be possible to gain insight on gene expression regulatory mechanisms, 
as well as possibly discovering ways of combatting and/or attenuating certain kinds of 
viral infections. xrRNAs can potentially be used in molecular biology to protect desired 
mRNAs from degradation, which should result in increased protein synthesis after the 
genes encoded within those decay-resistant mRNA fragments are translated. This work 
concentrates on investigating the effects of addition of xrRNAs to previously-
characterized yeast reporters by qualitative and quantitative analysis of the protein and 
mRNA content of the resulting cells. 
 
1.1.1 Transcription  
 The lifecycle of an mRNA molecule begins with transcription. By definition, 
transcription is the formation of an RNA molecule from a DNA template and requires the 
use of a DNA-dependent RNA polymerase. In eukaryotes, the main enzyme responsible 
for mRNA transcription in the nucleus is RNA polymerase II (RNAP II). Transcription 
begins when RNAP II is recruited to the promoter region of a protein-coding gene with 
the help of several general transcription factors (GTFs). A promoter region is a sequence 
element in the DNA that is recognized by specific transcription factors as a binding site, 
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triggering a cascade of events that lead to transcription initiation. Promoters can be 
constitutively active (e.g. house-keeping genes), or inducible, in which genes are turned 
on or off in response to changes in cellular conditions. An example of an inducible 
promoter is the galactose promoter that regulates the transcription of genes required for 
galactose catabolism, which ensures that the genes are transcribed if (and only if) they are 
required for cell growth and survival (Douglas and Condie, 1954; Douglas and 
Hawthorne, 1964). Since glucose is a repressor of the galactose promoter, and galactose 
is an activator, the genes are only transcribed in the absence of glucose and presence of 
galactose. Otherwise, the cells rely on glucose catabolism, which provides more ATP per 
molecule and is thus the favorable catabolite. The use of a galactose-inducible promoter 
in cellular biology allows for a higher control of experimental conditions, since the genes 
can easily be turned on or off as needed by simply switching the growth media. 
Five GTFs have been shown to be essential for transcription and are highly 
conserved in all eukaryotes: TFIID, TFIIB, TFIIF, TFIIH, and TFIIE (Orphanides et al, 
2019). For RNAP II-mediated transcription, a subunit of TFIID (TBP, or TATA-Binding-
Protein) recognizes and binds to the TATA element present in a great variety of 
promoters. TFIIB then recognizes the TFIID-promoter complex and binds, followed by 
binding of TFIIE, TFIIH and TFIIA to complete the preinitiation complex. The DNA 
strands are separated around the promoter region (promoter melting), providing the 
single-stranded template necessary for RNAP II to begin mRNA synthesis. Transcription 
begins with extensive phosphorylation of the carbon-terminal domain (CTD) of RNAP II 
by TFIIH, and formation of the first phosphodiester bond between two RNA bases. 
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1.1.2 Processing and Transport 
 Processing of the RNA transcript into a mature mRNA occurs cotranscriptionally 
with three major reactions: capping, splicing, and polyadenylation. This process begins 
when the emerging RNA transcript is about 20-30 nucleotides long by the addition of a 5’ 
cap. This occurs in three steps: 1) the triphosphate of the first RNA nucleotide is 
hydrolyzed by RNA triphosphatase, resulting in a bisphosphate group, 2) A GMP is 
added to the bisphosphate via a 5’-5’ linkage by a guanyltransferase, and 3) The N7 
position in the added GMP is methylated by a methyltransferase, resulting in the 5’ 7-
methylguanylate cap (m7G) (Proudfoot et al, 2002). The unusual 5’-5’ linkage of the m7G 
cap provides stability to the RNA molecule (Beelman and Parker, 1995) and is 
recognized by the cap-binding complex (CBC), which remains bound to the mRNA until 
it has been exported to the cytoplasm. 
 In general, eukaryotic genes are made up of coding regions (exons) interrupted by 
noncoding regions (introns). Splicing is the removal of introns and merging of exons into 
a single open-reading frame that can be subsequently translated into protein. Splicing 
occurs via two reactions (each followed by transesterification): 1) Nucleophilic attack of 
the 2’OH on the branchpoint adenosine onto the 5’ end of exon 1, resulting in a lariat 
intermediate and a free exon 1, and 2) Nucleophilic attack of 2’OH of exon 1 ono the 5’ 
end of exon 2, resulting in the spliced pre-mRNA and free intron (More and Sharp, 
1993). These reactions are facilitated by the spliceosome, made up of small nuclear 




 Most mRNAs contain a 3’ end made up of about 250 adenosine residues, known 
as the poly(A) tail. Before the poly(A) tail is added, the pre-mRNA is cleaved 
downstream from the polyadenylation signal, which is a highly conserved hexamer of 
sequence AAUAAA, followed by a downstream sequence element (DSE) composed of a 
U- or GU-rich motif. Cleavage and polyadenylation specificity factor (CPSF) binds 
directly to the hexameric polyadenylation signal and is the main enzyme responsible for 
cleavage of the pre-mRNA approximately 10-30 nucleotides downstream from its 
binding site (usually between the hexamer and DSE). Cleavage usually occurs before 
transcription termination, and cleavage stimulation factor (CStF) binds to both the RNA 
and RNAP II, signaling it to release the transcript (Glover-Cutter, 2008). Once the pre-
mRNA has been cleaved, the enzyme polyadenylate polymerase (poly(A) polymerase) 
catalyzes the addition of single adenosine monophosphate units to the 3’ end, until the 
tail is approximately 250 nucleotides long (For review, see Wahle and Ruegsegger, 
1999). 
 Once capped, spliced, and polyadenylated, mature mRNAs can be transported 
from the nucleus to the cytoplasm. Mature mRNAs remain bound to several proteins, 
forming mature messenger ribonucleoproteins (mRNPs). The associated proteins serve to 
stabilize the RNA, and direct it to the cytoplasm. Among these proteins, the CBC plays a 
crucial role in transport through the nuclear pore complex, along with the DEAD box 
protein, Dbp5 (Hamm, 1990; Rocak and Linder, 2004). Once in the cytoplasm, the 





 A mature mRNP consists of at least one protein-coding gene, also called open 
reading frame (ORF), flanked by 3’ and 5’ untranslated regions (UTRs), protected by a 5’ 
cap and 3’ poly(A) tail, and complexed with several proteins. The translation of mRNAs 
primarily occurs by a 5’ cap-dependent pathway: initiation of translation involves the 
interaction of the ribosome, among other key proteins, with the 5’ cap and 5’ UTR of the 
mRNA. Proteins importin-α and importin-β are responsible for exchanging the CBC with 
the cap-binding protein eIF4F (eukaryotic Initiator Factor 4F), which mediates the 
initiation of the standard cap-dependent translation (Sato and Maquat, 2009; 
Gonatopoulos-Pournatzis and Cowling, 2013).  
 Eukaryotic ribosomes (80S) are composed of two subunits: the small subunit 
(40S) and the large subunit (60S). The first step in translation initiation involves the 
binding of the initiator tRNA (Met-tRNAi
Met) to the P site of the small ribosomal subunit. 
This is achieved with the help of eIF2, which complexes with the tRNA, the 40S subunit 
and GTP, which is required for translation initiation (Sonenberg and Dever, 2003). The 
resulting eIF2•GTP•Met–tRNAi
Met ternary complex (FIGURE 1), joined by the 40S 
subunit, eIF1, eIF1A, eIF3 and eIF5 form the 43S preinitiation complex (PIC) (Algire et 
al., 2002). The PIC is recruited by eIF4F. eIF4F consists of three subunits: eIF4A, eIF4E 
and eIF4G. eIF4E is responsible for binding to the 5’ cap, while eIF4A serves as an 
ATPase and ATP-dependent RNA helicase (Sonenberg, 1996). eIF4G is a scaffold 
protein that also binds eIF3, which associates with the 40S ribosomal subunit (Pain, 
1996). The poly(A)-binding protein (PABP) binds to the poly(A) tail, which has been 
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shown to be essential for effective translation initiation (Jacobson, 1996; Sachs et al, 
1997). In yeast, PABP has been shown to associate with eIF4G (Tarun and Sachs, 1996). 
In poly(A) tail-dependent translation, the mRNA circularizes following the closed loop 
model, in which the 3’ end of the mRNA loops around to the 5’ end (Kahvejian, 2001; 
Tarun and Sachs, 1996). 
 
FIGURE 1. Assembly of the eukaryotic 80S ribosome capable of translation 
initiation. The eIF2•GTP•Met–tRNAi
Met ternary complex is vital for proper formation of 




Once formed, the PIC is recruited to the 5’ cap of the mRNA and, once bound, 
scans the 5’ UTR of the mRNA in the 5’3’ direction until it locates the start codon, 
AUG (Hinnebusch, 2011). Once the start codon is reached, the PIC releases eIF1, which 
triggers a change in conformation of the complex and GTP hydrolysis, releasing an 
inorganic phosphate.  eIF5, the GTPase responsible for this hydrolysis reaction, and 
eIF2•GDP are subsequently released (Maag et al, 2005). The eukaryotic initiation factors 
1A and 5B (a second GTPase) mediate the assembly of the 60S ribosomal subunit, 
forming the 80S initiation complex. Binding of the 60S subunit triggers GTP hydrolysis 
by eIF5B, which leads to conformational changes in the complex, resulting in release of 
eIF5B (Pestova et al, 2000). Finally, eIF1A is released (Acker et al, 2009), resulting in a 
fully-assembled 80S ribosome capable of protein synthesis (For comprehensive review of 
translation initiation, see Aitken and Lorsch, 2012). 
 Elongation begins with the initiator tRNA bound to the P (peptidyl-tRNA) site of 
the 80S ribosome. The eukaryotic elongation factor 1α (eEF-1α), which binds to GTP and 
the aminoacyl-tRNA, directs the binding of the corresponding amino acid to the next 
codon in the mRNA sequence, located at the A site. When the correct match has been 
made, GTP is hydrolyzed, eEF-1α •GDP is released, and the aminoacyl-tRNA is placed 
at the A site. The peptidyl transferase center located in the 60S subunit can then catalyze 
peptide bond formation between the two amino acids in the P and A sites. The initiator 
methionine is released from the P site, transferring the nascent polypeptide onto the A 
site. The mRNA is shifted down one codon, leaving the deaminoacylated initiator tRNA 
at the E (exit) site, and the tRNA containing the polypeptide chain at the P site. The 
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translocation step is mediated by eEF-2, and also requires GTP hydrolysis. The initiator 
tRNA exits and a new aminoacyl-tRNA enters at the A site. This cycle is repeated for the 
rest of the coding region of the mRNA (Merrick, 1992), until one of three stop codons is 
reached (UAA, UGA, or UAG). Termination of translation begins when the stop codon is 
recognized by eukaryotic release factor 1 (eRF1). After eRF3 hydrolyzes GTP, eRF1 
releases the polypeptide from the tRNA located in the P site (Hellen, 2018). The post-
termination complex is subsequently disassembled, freeing all the components and 
allowing them to enter another cycle of translation. 
 
1.1.3.1 Eukaryotic Versus Prokaryotic Translation 
There are important distinctions between eukaryotic and prokaryotic mRNAs. As 
explained above, in eukaryotes, the processes of transcription and translation are 
separated in space and time. Prokaryotic cells, on the other hand, do not contain a nucleus 
and therefore do not require transport of mRNAs to the cytoplasm. In prokaryotes, the 
processes of transcription and translation do not only occur in the same place, but also 
can occur simultaneously. Prokaryotic translation can begin before the process of 
transcription is complete, with ribosomes having the capability of binding to nascent 
mRNAs. In comparison to eukaryotic mRNAs, prokaryotic mRNAs require almost no 






1.1.3.2 Internal Ribosome Entry Sites (IRES) 
Another important distinction is the number of genes encoded in each mRNA. 
Eukaryotic mRNAs are typically monocistronic, indicating that each mRNA contains a 
single ORF, encoding for a single polypeptide. In contrast, prokaryotic mRNAs can 
contain multiple ORFs. Only the first ORF in a polycistronic mRNA can be translated via 
cap-dependent translation, since the ribosome-mRNA interaction is broken once the 
ribosome reaches the stop codons present at the 3’ end of the first ORF. An internal 
ribosome entry site (IRES) is a cis-acting RNA element that, when present upstream from 
a coding region, can be recognized by and act as a binding site to a ribosome, thus 
allowing for cap-independent translation. IRES structures were first discovered in 
picornaviral mRNAs (Jang et al., 1988; Pelletier and Sonenberg, 1988), and were 
originally believed to function exclusively in prokaryotes (Kozak, 1979; Kanarska et al., 
1981), since eukaryotic ribosomes were reportedly unable to bind circular mRNAs. The 
picornaviral IRES was found to be a 450-nucleotide structure located at the 5’UTR of the 
viral genome (Jackson et al., 1990). Initiation of translation via an IRES differs from the 
canonical mechanism, since the ribosome binds directly to the entry site, rather than 
scanning for the start codon after binding to the 5’ end. The notion that IRES structures 
could only function in prokaryotes was disproven when it was shown that insertion of this 
structure into the intron of bicistronic eukaryotic mRNAs could mediate translation 
initiation via internal entry of the ribosomes (Jang et al., 1988; Pelletier and Sonenberg, 
1988). Up to date, a large number of non-prokaryotic IRES structures have been found, 
11 
 
both in viral and eukaryotic mRNAs encoding for a wide range of proteins (For review, 
see Hellen and Sarnow, 2019). 
 
1.1.3.2.1 Mechanisms of Internal Ribosomal Entry 
 Current knowledge suggests that there is no universal IRES structure or 
mechanism of internal ribosomal entry. No important parallels have been made in respect 
to size, sequence, or structure between all known IRES elements. So far, three 
mechanisms of translation initiation via internal ribosomal entry have been differentiated. 
The first mechanism is observed in members of the Picornaviridae family. Although 
IRES elements have been discovered for all known members of this viral family, there 
are at least three distinct structural motifs observed, with members of each genus 
displaying similar characteristics (Brown et al., 1991; Borman and Jackson, 1992; Hinton 
and Crabb, 2001; Bakhshesh et al., 2008). Despite their structural features, all IRES 
elements of the Picornaviridae family recruit the ribosome with the help of translation 
initiation factors and RNA binding proteins, including eIF4G, the poly(A) binding 
protein (PABP) and the eIF3/eIF2•GTP•Met–tRNAi
Met ternary complex. In short, eIF4G 
and PABP interact around the IRES elements, leading to a pseudo-circularization of the 
mRNA that is similar to that observed in cap-dependent translation (Martinez-Salas et al., 
2015). In contrast to the factor-dependent mechanism observed in the Picornaviridae 
family, the IRES from hepatitis C virus (HCV) is able to bind the 40S ribosomal subunit 
in the absence of any initiator factor. The HCV IRES is a 410-nucleotide-long stem-loop 
secondary structure that consist of most of the viral 5’ UTR and interacts directly with the 
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40S subunit, which in turn binds to eIF3. The start codon has been shown to be located 
on loop IV of the structure, right on (or very near) the P-site of the bound ribosomal 
subunit (Pestova et al., 1998). 
 
1.1.3.2.2 Translation Initiation without Initiator tRNA (The CrPV IRES) 
 The third method of internal ribosomal entry, discovered in the cricket paralysis 
virus (CrPV), is not only independent of initiator factors in order to achieve IRES•40S 
subunit complex formation, but also does not require eIF2, an initiator tRNA, or GTP 
hydrolysis in order to achieve the fully-functional IRES•80S ribosome complex (Hellen 
and Sarnow, 2019). The CrPV IRES has been shown to bind the 40S ribosomal subunit, 
then recruit the 60S subunit directly, initiating translation from the A site (rather than the 
P site) of the ribosome (Wilson et al., 2000). Internal translation initiation by the CrPV 
IRES also differs from the canonical mechanism in that the first amino acid in the 
resulting polypeptide is not methionine, but either alanine or glutamine (Sasaki and 
Nakashima, 1999).  
The CrPV IRES is 192 nucleotides long, commonly forming an extensive triple-
nested pseudoknot (Kanamori and Natashima, 2001; Thompson and Gulyas, 2001; 
Schüler et al., 2007). It contains a smaller pseudoknot structure (42 nucleotides long) at 
the 3’ end that has been shown to be essential for translation initiation, since internal 
translation initiation has been disrupted in mutants that exhibit improper pseudoknot 
formation (FIGURE 2) (Sasaki and Nakashima, 1999; Domier et al., 2000, Wilson et al, 
2000). The pseudoknot is immediately followed by the coding triplet, which is either  
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 FIGURE 2. Stereo view of ribosome-bound CrPV IRES structure (PDB 2NOQ, 
adapted from Schuler et al., 2007). Mutations that prevent formation of the small 3’end 
pseudoknot formation and inhibit internal ribosomal initiation are highlighted in yellow. 
 
 
GCU or GCA in all CrPV-like IRESs that have been studied. Helical regions of the 
CrPV-like IRES elements are believed to play a key structural role, since there is high 
sequence specificity in these regions (Hellen and Sarnow, 2019). The mechanism through 
which the CrPV IRES recruits the ribosome is believed to be an unprecedented stance of 
tRNA- and mRNA-mimicking, since recent cryo-microscopy structures of an 
IRES•Ribosome•aminoacyl-tRNA complex show a conformation in which the IRES 
binds to the E site of the ribosome mimicking the acceptor stem of a tRNA (Pisareva et 
al., 2018). The structures shows a doubly-translocated IRES structure with the 
aminoacyl-tRNA occupying the P site. This suggests that the IRES is not only able to 
trigger translation initiation without the need for the initiator tRNA, but that it is also able 
to translocate twice (lacking prior peptide-bond formation), leaving the ribosome ready 
CrPV IRES 
CrPV IRES mutations 
18S ribosomal RNA 
25S ribosomal RNA 
60S ribosomal protein 
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for elongation. Thus, the IRES element can mimic mRNA in order to recruit the 40S 
subunit of the ribosome, and mimic tRNA in order to initiate protein synthesis. This 
double-mimicking mechanism allows the CrPV IRES to bind the ribosome and prime it 
for translation elongation, without the need for eukaryotic initiation factors.   
 
1.1.4 mRNA Half-Lives and Stability 
 Once an mRNA molecule has been transcribed, it has a specific lifetime after 
which it is broken down into individual bases, which can be subsequently recycled into 
new mRNAs. Mammalian mRNAs have been found to have half-lives ranging from a 
few minutes to over 24 hours (Sharova et al., 2009). Even mRNAs with very short half-
lives can be translated more than once. Once an 80S ribosome has assembled at the 5’ 
end of the mRNA and translation has initiated, the ribosome will travel in the 5’3’ 
direction along the mRNA, decoding every codon and adding the corresponding amino 
acid to the growing peptide chain, until it reaches a stop codon. This frees up the 5’ end, 
enabling a second ribosome to assemble, and so on, resulting in several ribosomes loaded 
onto a single mRNA. Furthermore, following the closed-loop model, once the ribosome 
reaches the stop codon at the 3’ end of the mRNA, the 5’ end is in close proximity, 
allowing for the newly released ribosome to bind again and begin a new round of 
translation. In human cells, the protein-to-mRNA ratio has been found to vary greatly, 
ranging from 1x102 to 1x108, with most ratios ranging over more than two orders of 
magnitude (Eraslan et al., 2019).  
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An important factor affecting mRNA lifetime is its stability, which in turn can be 
determined by its sequence and structure (Ross, 1995). Primary and secondary structure 
of an mRNA are cis-determinants of its stability. These cis-determinants include the 
poly(A) tail, 5’ and 3’ UTRs, and the mRNA coding region. In general, these cis-
enhancers of stability are sequences that can basepair to form a more stable secondary 
structure; even the smallest changes in secondary structure have been found to have the 
ability to influence mRNA half-lives (Weiss and Liebhaber, 1994). There are many other 
factors that determine the stability of an mRNA, including its translation rate, cellular 
location and environment, as well as the presence of regulatory factors. Trans-acting 
factors include RNA-binding proteins that shield mRNAs from degradation, including 
PAPB (Ross, 1995).   
 
FIGURE 3. The concentration of mRNAs in the cell is highly dependent on the 
rates of two opposing processes: transcription and mRNA decay. Similarily, the major 
factors affecting protein concentrations are: mRNA abundance, and rates of translation 
and protein degradation.  
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1.1.5 mRNA Turnover 
After an mRNA has fulfilled its biological role, it must be degraded in order to 
prevent buildup of products and intermediates in the cell (FIGURE 3). As previously 
discussed, eukaryotic mRNAs are stabilized by interactions of the 5’ cap and the poly(A) 
tail with eIF4G and PAPB. The poly(A) tail is progressively shortened over time 
(Sheiness and Dernell, 1973). The process of mRNA degradation begins once the length 
of the poly(A) tail is approximately 10 nucleotides long, making the oligo(A) tail too 
short to maintain a physical interaction with PAPB (Decker and Parker, 1993; Muhlrad 
and Parker, 1992; Muhlrad et al., 1994). After this, the mRNA is degraded by one of two 
redundant pathways: the exosome-mediated 3’5’ pathway, or in the decapping- 
dependent 5’3’ pathway. In the 3’5’ pathway, the unprotected 3’ end is attacked by 
the exosome, which is a large complex of 3’5’ exoribonucleases (Mitchell and 
Tollervey, 2003; Garneau et al., 2007). 
In the 5’3’ decay pathway, the shortening of the poly(A) tail, which is thought 
to in turn destabilize the cap-binding complex, is followed by decapping. The main 
enzyme responsible for decapping in yeast is Dcp1p, which is believed to recognize the 
mRNA substrate by interacting with both the 7-methyl group on the cap structure and the 
RNA portion of the mRNA (LaGrandeur and Parker, 1998; Caponigro and Parker, 1996). 
Removal of the m7G cap exposes a 5’ monophosphate which is the substrate for the 
enzyme Xrn1 (Hsu and Stevens, 1993; Muhlrad et al., 1994). The exonucleolytic activity 
of Xrn1 continues in the 5’3’ direction, removing one nucleotide at a time and 
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FIGURE 4. Overview of 5’3’ mRNA decay pathway. The mRNA is committed 
to decay after progressive deadenylation of the poly(A) tail results in a short oligo(A) tail. 
Degradation continues by removal of the m7G cap by a decapping enzyme, which 
exposes a 5’ monophosphate that is the substrate for the exoribonuclease, XRN1. XRN1 
is the major 5’3’ exoribonuclease and completely degrades the remainder of the 






1.2 Partially-Decayed RNAs 
1.2.1 Flaviviridae and Sub-Genomic RNAs 
Flaviviruses are pathogenic plus-sense single-stranded RNA viruses that include 
the West Nile virus, Zika virus, and yellow fever virus (Westaway, 1985). Upon 
infection, flaviviruses utilize the host’s cellular enzymes in order to replicate their 
genomic RNA. In addition, this process also generates noncoding RNA’s called 
subgenomic flavivirus RNAs (sfRNAs) that are linked to increased pathogenicity 
(Pijlman et al., 2008; Liu et al., 2014). These sfRNAs are now known to be the result of 
incomplete decay by the exonuclease Xrn1 (Jones et al., 2012). This is due to the 
formation of pseudo-knot structures found in the 3’ untranslated region of the viral 
genome (3’UTR), which halt the progression of Xrn1 in the 5’3 direction (Chapman et 
al., 2014a, 2014b, Akiyama et al., 2016), protecting any downstream genetic material 
from degradation in that direction. The pseudoknot is composed of a three-helix junction, 
through which the 5’ end is threaded, thus providing a mechanical barrier against Xrn1’s 
exonucleolytic activity (FIGURE 5). These Xrn1-resistant structures (xrRNAs) can 
potentially be used to target certain genes from degradation and are expected to increase 
protein synthesis of such genes.  
 
1.3 S. cerevisiae as a Model Organism 
 Yeast are unicellular eukaryotes that can reproduce either by sexual or asexual 
reproduction. Being one of the simplest eukaryotic organisms, yeast make popular model 
organisms for laboratory studies. The baker’s or budding yeast, Saccharomyces 
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cerevisiae, is one such model organism. The S. cerevisiae genome was the first 
eukaryotic genome to be fully sequenced (Goffeau et al., 1996) and is very well 
characterized. S. cerevisiae cells are easy to grow and maintain, due to their short 
generation time and flexibility to adjust to changing environmental conditions. 
Furthermore, their genome is easily manipulated and a full collection of ORF knockouts 
exists (Shoemaker et al., 1996; Chu and Davis, 2008), making S. cerevisiae an ideal 
candidate for molecular biology studies. 
 
 
FIGURE 5. ZIKV xrRNA front and side views.  5’ end (blue) threaded through 
the center of a 3-helix junction (3’ labeled red). The pseudoknot forms a mechanical 
barrier which prevents progression of the 5’3’ exonuclease XRN1 (PDB 5TPY, 







1.3.1 S. cerevisiae Genomics 
 The S. cerevisiae genome is 12,068 kilobases long and encoded 5885 proteins, 
140 ribosomal RNAs, 40 small nuclear RNAs, and 275 transfer RNAs, all found within 
the yeast’s 16 chromosomes (Goffeau et al., 1996). The reference genome is S288C, 
which is stored in the Saccharomyces Genome Database (https://www.yeastgenome.org) 
and has a genotype of MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho bio1 bio6 (See 
below) (Mortimer and Johnston, 1986).  
Cells can be either haploid or diploid, and both types of cells can reproduce 
asexually by mitosis through budding, a process through which a daughter cell buds off a 
mother cell. Haploid cells can also reproduce sexually by mating with cells of the 
opposite mating type. The two different type of cells, a and α, produce mating 
pheromones called a-factor and α-factor, respectively. Each mating type can only 
respond to the opposite mating pheromone, and the a-type cells respond to the presence 
of the a-factor by growing a projection called a shmoo toward the source of the mating 
factor. In contrast, diploid cells can undergo meiosis and sporulation under conditions of 
stress, producing four haploid spores, two of each mating type, which can subsequently 
reproduce sexually (For review, see Duina et al., 2014; Billard et al., 2012).  
 By convention, yeast gene symbols contain three italic lowercase letters followed 
by an Arabic number of the identifying mutation, and uppercase identifies a dominant 
gene while a lowercase identifies a recessive gene. Alleles are listed as the gene symbol, 
followed by a hyphen and an italic Arabic number. Alleles that have been altered 
recombinantly are listed by the gene symbol followed by a specification on the type of 
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alteration performed: (::) for a disruption, (-Δ) for a deletion, and (Δ::) for a replacement. 
Proteins are written as the gene symbol, non-italicized, with the first letter uppercased, 
and followed by the suffix “p”. Phenotypes are listed as the non-italic three letters of the 
gene symbol (first letter uppercase), followed by a superscript “+” sign for wild-type and 
“-” sign for mutant. When listing the genotype, the mating type loci are normally listed 
first, followed by the gene symbols of the mutated and recombinant genes (Cherry, 
1998).  
 
1.3.2 Auxotrophy as a Selective Marker 
 Auxotrophy refers to the inability of a particular organism to synthesize a 
metabolite needed for its growth and reproduction. By definition, the wild-type (WT) 
strain is a prototroph, indicating that it can synthesize all the nutrients required for its 
survival. Through a mutation in a key gene, a new mutant strain can be created that 
enables for auxotrophic selection. For example, the ura3-52 mutation, caused by an 
insertion of the transposable element Ty into the coding region of the URA3 gene 
encoding for Orotidine 5'-phosphate decarboxylase (ODCase), transforms the mutant 
cells into uracil auxotrophs (Rose and Winston, 1984; Flynn and Reece, 1999). If a 
plasmid containing the URA3 ORF is used to transform these auxotrophs, only the cells 
that were successfully transformed with the plasmid will be able to grow in minimal 





1.3.3 IRES in Yeast 
 Although many functioning eukaryotic IRES elements had been found, successful 
internal ribosomal entry had not been reported in yeast until Thompson et al. (2001) 
reported efficient translation of the second gene in a bicistronic reporter in S. cerevisiae, 
through the use of the CrPV IRES. Although the authors reported poor translation 
efficiency in WT cells, they found that cap-independent translation was markedly 
increased in the H2545 strain (Dever et al., 1995), which contains disrupted imt3 and 
imt4 genes, encoding for two initiator tRNAs. Disrupting expression of these two 
tRNAmet genes decreases the intracellular concentration of the eIF2•GTP•Met–tRNAi
Met 
ternary complex, enhancing the rate of cap-independent translation.  
 
1.4 THESIS OBJECTIVE 
This work focuses on the investigation of the effect of artificially-installed 
xrRNAs into previously-characterized splicing reporters (Mayas et al., 2010), through 
transformation of S. cerevisiae cells with reporters with and without functioning xrRNAs 
and IRES elements. In vivo assays examine enzymatic activity in the cells, as well as 
quantify relative protein and RNA transcript content upon transformation with the 
different reporters. Through these experiments designed to prove the behavior of the 
reporters, this work aims to answer the fundamental research question of whether 
mRNAs containing artificially-installed xrRNAs can be translated into protein, and 
whether they lead to accumulation of decay-resistant transcript and increased levels of 
protein expression. The reporter of choice is a bicistronic plasmid containing the ACT1 
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gene (and its intron), followed by the LACZ gene. The reporter also contains the URA3 
gene as a marker. The xrRNAs have been inserted into the intergenic region, followed by 
the CrPV IRES. The two viral elements are hypothesized to be able to work in tandem, to 
allow cap-independent translation of the decay-resistant mRNA fragments (FIGURE 6).  
 
 
FIGURE 6. Translation of partially-decayed messenger RNAs. Addition of the 
decay-resistant structures (xrRNAs) to the reporters should result in accumulation of 
partially-decayed transcripts. Since these transcripts contain the CrPV IRES structure to 
allow for cap-independent translation, translation of partially-decayed mRNAs should 
result in increased protein synthesis. 
 
 
1.4.1 Research Aim 1. Detection of Decay-Resistant Transcripts 
RNA transcripts can be quantified directly through primer extension followed by 
fragment analysis through capillary electrophoresis. Reverse transcription is initiated by 
landing a complementary fluorescently-labeled DNA primer onto the RNA transcripts. 
After extension by an RNA-dependent-DNA-polymerase and subsequent degradation of 
remaining RNA, complementary DNA (cDNA) is obtained. The cDNA can be analyzed 
through capillary electrophoresis. After applying an electric field to the capillary, cDNA 
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will travel to the positive electrode with a speed reversely proportional to its length. 
Detection of the fluorescently labeled cDNA and integration below the curve of the 
corresponding peaks allows for quantification of the nucleic acid at each detected length. 
 
1.4.2 Research Aim 2. Quantification of Enhancement in Protein Expression 
Since the LACZ gene is located downstream from the xrRNAs, the protective 
effect of these structures from the decay machinery can be examined by comparing the 
transcription of the gene in cells expressing reporters with and without the xrRNAs. 
Furthermore, since the IRES element should allow for cap-independent translation of the 
β-galactosidase enzyme encoded by LACZ, protein expression of β-galactosidase can be 
quantified and compared. The activity of β-Galactosidase is commonly quantified 
through the β-Galactosidase assay. In vivo, β-Galactosidase is responsible for cleaving 
lactose into glucose and galactose. The compound o-nitrophenyl-β-D-galactoside 
(ONPG) is also recognized as a substrate and is cleaved into galactose and ο-nitrophenol, 
which has an observable yellow color and absorbs light at 420 nm. This allows for both 
qualitative and quantitative examination of β-Galactosidase activity in vitro. When cell 
lysates are incubated with excess ONPG, the production of o-nitrophenol over time is 
proportional to the concentration of β-Galactosidase. This is quantifiable through the 
absorbance at 420 nm and normalized by time and initial cell concentration. 
While the β-Galactosidase assay can be used to quantify enzymatic activity, 
which should be proportional to protein concentration, protein content can be directly 
measured through western blotting. Analysis of whole protein cell content can be 
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performed by lysing the cells in order to solubilize cellular proteins in a lysis buffer, 
which can subsequently be ran through a gel in order to separate all the proteins by size 
using gel electrophoresis. After transfer of the proteins from the gel to a nitrocellulose 
membrane, the whole cell protein lysate can be examined for the content of a specific 
protein using target-specific antibodies. Through the use of a primary antibody specific to 
β-galactosidase, followed by a fluorescently-labeled secondary antibody specific to that 
primary antibody, the presence of β-galactosidase can be detected. This allows for the 
semi-quantitative analysis of relative protein content with the reporters with and without 










CHAPTER 2: MATERIALS AND METHODS 
2.1 Strains and Plasmids. 
       
Strain Relevant Genotype  Parental Strain 
Reference or 
source 
S288C MATα SUC2 gal2 mal2 mel 




H2545 MATa trp1-D1 ura3-52 IMT1 
IMT2 imt3::TRP1 imt4::TRP1 
leu2::hisG GAL1 
 
Thomspon et al., 
2001; Dever et al., 
1995 
CRY1 MATa ade2-1 can1-100 his3-
11,15 leu2-3,-112 trp1-1 ura3-1 
W303-1A Cherry et al., 
2019; Brickner & 
Fuller, 1997 
YJH632 MATa ade2-1 can1-100 his3-
11,15 leu2-3,-112 trp1-1 ura3-
2, xrn1∆::HygMX 
CRY1 Cherry et al., 2019 
YJH898 MATa ade2-1 can1-100 his3-
11,15 leu2-3,-112 trp1-1 ura3-
3, dxo1∆::KanMX 
CRY1 Cherry et al., 2019 
YJH867 MATa ade2-1 can1-100 his3-
11,15 leu2-3,-112 trp1-1 ura3-
4, xrn1∆::HygMX, 
dxo1∆::KanMX 
CRY1 Cherry et al., 2019 
TABLE 1. Strains used. 
 
Yeast parental strain S288C was purchased from Fisher Scientific and 
manufactured by GE Dharmacon™ (Dharmacon catalog # YSC1060) and was used as a 
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reference strain for all knockout-confirmation colony PCR experiments. Strain H2545 
was used for all protein expression experiments utilizing the JPS 1480 series reporters, as 
well as fragment analysis. β-Galactosidase assay was also performed on CRY1 strains 
(Obtained from Patrick D. Cherry) and its derived mutants expressing the JPS 1480 series 
reporters (TABLE 1). 
 
 
 FIGURE 7. JPS 1480 series reporters. All plasmids were kindly provided by the 
Jonathan P. Staley lab.  
 
 
JPS 1480 series reporters (FIGURE 7) were obtained from Jonathan P. Staley’s 
lab (Mayas et al., 2010). All reporters are bicistronic and include a 5’ m7G cap, the Act1 
gene, and the CrPV IRES followed by the LacZ gene and a poly(A) tail (JPS 1481). In 
addition, the JPS 1481X reporter contains the xrRNAs immediately preceding the CrPV 
IRES. The JPS 1481M reporter contains the sequence for the xrRNAs but with a 3-
nucleotide mutation along each of the two copies of the pseudo-knots (FIGURE 9) which 
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prevent the proper folding of the structures. The JPS 1482 and 1482X reporters contain a 
2-nucleotide mutation along the IRES, which render the IRES inactive (FIGURE 2, 9). 
 
2.2 Yeast Husbandry. 
All cells were incubated at 30 °C. Liquid cultures were incubated for the specified 
amount of time, and all cultures on the surface of plates containing solid media, unless 
specified, were grown for 2-3 days. Strain H2545 was grown in complex Yeast Peptone 
Dextrose media (YPD), containing 1 g/L bacto yeast extract, 2 g/L peptone, 2 g/L d-
glucose (dextrose), and 2 g/L agar (for plates only). Solutions were sterilized by 
autoclaving. Strains S288C and CRY1 were grown in complex YPD plus Adenine media 
(YPAD, which has the same composition of YPD plus 0.004% adenine sulfate 
(supplementation with adenine inhibits reversion of ade1 and ade2 mutations present in 
CRY1 cells, which cause red coloration on the yeast colonies. Dorfman, 1969). CRY1 
knockout strains were grown YPD media supplemented with either 200 µg/mL 
Hygromycin B for XRN1 knockouts, or 300 µg/mL G18 for DXO1 knockouts (or both for 
ΔXRN1/ΔDXO1). 
Uracil auxotrophic strains expressing the JPS 1480 series reporters were grown in 
Synthetic Defined media containing 2% d-glucose and lacking uracil (SD/-ura). 
Composition of SD/-ura is 5 g/L ammonium sulfate, 1.7 g/L yeast nitrogen base without 
amino acids, 2 g/L drop out synthetic mix (-his, -leu, -trp, -ura) without yeast nitrogen 
base (US Biological cat. #D9540), 40 mg/L tryptophan, 160 mg/L leucine, 20 mg/L 
histidine, and 2 g/L agar for plates. Solutions without amino acids or sugar were 
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autoclaved, and supplemented with sterile-filtered stock solutions (4 mg/ml tryptophan 
solution, 8 mg/ml leucine solution, 4 mg/ml histidine, 20% (w/v) glucose). Note that if 
uracil is added to SD media, it is to a concentration of 20 mg/L. 
 
2.3  Transformation of Yeast Cells 
 Starter cultures were inoculated with the empty or WT cells and incubated 
overnight at 30 °C in 5 mL of the appropriate media (either YPD or YPAD). The 
overnight culture was used to seed a new 50 mL culture, which was grown to mid-log 
phase. The cells were pelleted at 3068 rcf for 10 minutes and supernatant was discarded. 
Cells were resuspended in 50 mL Molecular Biology Grade water (MBG H2O) and 
pelleted at 3068 rcf for 10 minutes. After discarding supernatant, cells were resuspended 
in 500 µL 100 mM lithium acetate. Suspension was spun down and supernatant was 
discarded. Cells were resuspended in 50 µL MBG H2O and 10 µL salmon sperm DNA 
were added to spurn recombination. Approximately 1 µg of plasmid DNA was added, 
followed by 500 µL PLATE (40% PEG 3350, 100 mM LiOAc, 10 mM TRIS7.5, 0.4 mM 
EDTA). The tubes were vortexed to homogenize and heated to 42 °C for 35-40 minutes. 
The resulting mixture was used to streak plates containing the selection media, SD/-ura. 
 
2.4 Sequencing 
 Plasmids were isolated from DH5α E. coli. competent cells previously 
transformed with each of the reporters. 5 mL bacterial cultures of LB media (10 g/L 
tryptone, 5 g/L yeast extract, and 5 g/L NaCl) supplemented with either 200 µg/mL  
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Primer Name Description  Sequence (5'-3') 
New LacZ PE LacZ, front 
end, reverse 
CCAGGGTTTTCCCAGTCAC 
EC JPS series 








Ana002  LacZ, Back 
end, forward 
CGGATTGATGGTAGTGGTCAAATGG 
Ana003 Cup1, Back 
end, forward 
CGACGATTCTACTCAGTTTTGAGTACAC 











































ampicillin (for all JPS 1480 reporters) or 100 µg/mL kanamycin (for BJH 872) for 
selection, were incubated overnight at 37 °C. Plasmid DNA was isolated using the ZR 
Plasmid Miniprep-Classic Kit obtained from Genesee Scientific (Catalog # 11-308A) and 
following the protocol specified in the kit. The resulting plasmid was diluted to a 
concentration of approximately 80 ng/ µL and mixed with 5 µL of primer at a 
concentration of 5 µM (TABLE 2). The samples were submitted for sequencing to 
Quintara Biosciences. Data obtained was analyzed using SnapGene®. 
 
 
2.5  Colony PCR 
Cells were grown in the appropriate solid media and incubated at 30 °C for 3 
days, until large colonies formed. One large colony (≈1-2 mm in diameter) was 
suspended in 50 µL lysis buffer (1% Triton-X 100 (v/v), 20 mM Tris-HCl pH8.5, and 2 
mM EDTA in MBG H2O) and heated at 95 °C for 10 minutes. Samples were centrifuged 
at 18,407 rcf for 10 minutes to remove cellular debris, and supernatant was transferred to 
a new tube. The resulting lysate was used as a template for each PCR reaction. 
      
Target Direction Sequence (5'-3') 
imt3 Forward GGATTTCATTCTAACACAGCTCAGTGTGC 
imt3 Reverse CCATTAATGAAGTGTTCTATATTGAGGC 
imt4 Forward GCGACATGGAGAGATAGAGATAGAAGAATTTG 
imt4 Reverse CAATTATTAATAATAACGCAGAAGTTAAAGC 
XRN1 A-Forward CCTCCTTTGCTCGTCTTTTCGCCACCACC 
XRN1 C-Forward TTCCAATCATAGGAGAAAACTTCTG 
XRN1 D-Reverse GCGGAAAGCTTTGTGTAAAAAATACCC 
DXO1 A-Forward GGCATTGTTGCATTACAGCGCCAG 
DXO1 D-Reverse GCCATCTTCCAATGTATTCTGGTATCG 
TABLE 3. Primers used for colony PCR knockout-confirmation experiments.  
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PCR reactions were setup containing: 4 µL of lysate, 2.5 µL 10 mM forward 
primer, 2.5 µL 10 mM reverse primer, 20 µL 1.25 mM dNTP mix, 10 µL 5X HF buffer 
(ThermoFisher Scientific catalog #F520L), 50 mM MgCl2 (ThermoFisher Scientific 
catalog #F518L, to a final concentration of 4 mM), 2.5 µL 0.5 µL 10% Phusion High-
Fidelity DNA Polymerase (v/v) (ThermoFisher Scientific catalog #F530L), and MBG 
H2O to a final volume of 50 µL. Primers used for each template are listed on TABLE 3. 
PCR amplification was performed in a thermal cycler programmed at 98 °C for 3 minutes 
for initial denaturation; followed by 35 cycles of denaturation at 98 °C for 30 seconds, 
annealing for 30 seconds at a temperature gradient of 55-70 °C, and extension at 72 °C 
for varying lengths of time for each template; and finalized by extension at 72 °C for 7 
minutes. Extension time was 30 seconds for imt3 and imt4, 3 minutes 30 seconds for 
XRN1, and 1 minute 30 seconds for DXO1. PCR products were mixed with 10 µL of 6X 
loading dye, and separated by electrophoresis at 100V for 1 hour in a 1% (w/v) agarose 
gel in Tris-Acetate-EDTA (TAE) buffer containing 0.5 µg/mL ethidium bromide. Gels 
were visualized using the Bio-Rad ChemiDoc™ MP Imaging System. Image was 
analyzed using Bio-Rad Image Lab™ 6.0 Software and labeled using Microsoft® 
PowerPoint®. 
 
2.6     Quantification of Enhancement in Protein Expression 
2.6.1  β-Galactosidase Assay 
Cells were grown to OD600≈0.5 in the appropriate media. 1.5 ml aliquots were 
pelleted and washed with Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 
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mM MgSO4; pH 7.0). Pellet was resuspended in 100 µL of Z-buffer and subjected to 
lysis through 6 cycles of freeze-thawing (freezing on liquid N2 followed by thawing in 
42°C water bath). Reaction was started through the addition of 700 µL of Z-buffer 
containing 1 mg∕mL ortho-nitrophenyl-β−galactopyranoside and 50 mM β-
mercaptoethanol. After incubation at 30 °C for 3 hours, reaction was quenched by adding 
of 500 µL 1M Na2CO3. Cell debris was pelleted and absorbance of the supernatant was 
measured at 420 nm using the Tecan Infinite® M1000 plate reader (also used to measure 
the initial OD600). Measurements were corrected for activity in wild-type cells and 
Miller units were calculated using EQUATION 1 (Miller, 1972).  
(EQUATION 1)        𝑀𝑖𝑙𝑙𝑒𝑟 𝑈𝑛𝑖𝑡𝑠 =  
𝑂𝐷420 𝑥 1000
𝑂𝐷600 𝑥 𝑇𝑖𝑚𝑒 (𝑚𝑖𝑛)𝑥 𝑉𝑜𝑙 (𝑚𝐿)
 
 
2.6.2 Western Blots 
Extraction of total yeast cellular protein content was performed as previously 
described (Kushnirov, 2000). Specifically, cell cultures were grown to OD600≈0.5, from 
which 4-6 mL aliquots were harvested and pelleted by centrifugation. Pellets were 
washed with 500 µL of ice-cold water, pelleted and resuspended in 100 µL of water. 
Cells were lysed by addition of 100 µL of 0.2 M NaOH and incubation at room 
temperature for 10 minutes. Cells were centrifuged at 15,871 rcf for 30 seconds and 
supernatant was discarded. Pellet was resuspended in 50 µL of 2x Laemmli Sample 
Buffer obtained from Bio-Rad, and 30 µL aliquots were loaded for separation by SDS-
page. After electrophoresis, proteins were transferred to a nitrocellulose membrane and 
immunoblotted with a rabbit β-galactosidase specific antibody (Novus Biologicals 
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catalog number NB300-327) and a rabbit GAPDH specific antibody as a loading control 
(Novus Biologicals catalog number NB300-327). Blots were then incubated with a goat 
anti-rabbit IgG antibody labeled with StarBright™ Blue 700 dye (Bio-Rad catalog 
number 12004162). Detection was performed using the Bio-Rad ChemiDoc™ MP 
Imaging System. Image was analyzed using Bio-Rad Image Lab™ 6.0 Software and 
labeled using Microsoft® PowerPoint®. 
 
2.7 Detection of Decay-Resistant Transcripts 
2.7.1 Fragment Analysis of Primer Extension Products 
RNA isolation was performed from cells grown to OD600 between 0.5 and 0.7 
and pelleted by centrifugation at 3068 rcf at 4°C. Cells were resuspended in 1000 µL of 
cold DNase/RNase-free H2O. Cells were centrifuged for 1 min at 6010 rcf, supernatant 
was removed and pellet was frozen on liquid N2. Pellet was thawed on ice and 
resuspended in 400 µL cold TES. 400 µL warm acid phenol was added, after which 
samples were vortexed for 15 seconds and incubated at 65°C for 30 minutes while 
vortexing for 15 seconds every 5 minutes. Samples were transferred to ice and incubated 
for 5 minutes, then centrifuged at 1503 rcf at 4°C for 10 minutes. Aqueous (top) layer 
was transferred to a new tube and 400 µL chloroform was added. After vortexing for 15 
seconds, samples were centrifuged at 18,407 rcf at 4°C for 10 minutes. Aqueous layer 
was transferred to a new tube and 40 µL 3M sodium acetate and 1000 µL 100% ethanol 
were added. Tubes were inverted to mix and incubated at -80°C for at least 20 minutes. 
After incubation, samples were centrifuged at 15,871 rcf at 4°C for 8 minutes. 
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Supernatant was carefully removed by micropipette and pellet was washed by adding 
cold 70% ethanol and inverting to mix. Samples were again centrifuged at 15,871 rcf at 
4°C for 8 minutes and supernatant removed by micropipette. Tubes were inverted and 
allowed to fully dry for around 30-60 minutes. The pellet (containing isolated RNA) was 
resuspended in 50 µL of DNase/RNase-free molecular-grade H2O, heating to 65°C for 5 
minutes if needed. The RNA was stored at -80°C. 
The yeast total RNA was diluted to a concentration of 400 ng/µL and reverse-
transcribed. 12.5 µL of the yeast RNA was mixed                                                                                                                                                         
with 2.5 µL hybridization mix (3.75 µM reverse-transcription primer labeled with 6-
FAM dye in 200 mM Tris pH 8, 200 mM NaCl, 40 mM DTT, can add 1.25 µM of a 
secondary primer as a loading control). Reverse transcription primer used was New LacZ 
PE (FIGURE S1, TABLE 2). Mixture was folded in the themocycler: 90°C for 3 minutes, 
55°C for 3 minutes, 4°C hold. Samples were removed and frozen on liquid N2. 1 µL 
GoScript™ Reverse Transcriptase (Promega, catalog number A5003) and 14 µL RT mix 
(1.6 mM each dNTP, 10 mM MgCl2, 167 mM Tris pH 8.3, 17mM DTT, 250 mM KCl) 
were added. Reverse transcription was performed in the thermocycler: 42°C for 45 
minutes, 55°C for 15 minutes, 65°C for 15 minutes, 20°C hold. After reverse-
transcription, remaining RNA was degraded by the addition of 3 µL 100 mM NaOH and 
incubation at 90°C for 3 minutes. Samples were spun down and purified on a G-25 
sephedex column (10%w/v beads in H2O). 25 µL formamide was added and samples 
were sent for fragment analysis to GeneWiz (Applied Biosystems™ GeneScan™ 600 
LIZ™ dye Size Standard added by GeneWiz), or Quintara Biosciences. Capillary 
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electrophoresis analysis performed by Quintara Biosciences were performed with either 
pre-added ROX 1000 ™, or 600 LIZ™ dye size standard added by Quintara Biosciences 
(Both size standards by Applied Biosystems™ GeneScan™). Fragment analysis data was 









CHAPTER THREE: RESULTS 
3.1 Vector Composition 
 The sequencing results confirmed the presence of all the key elements in the 
reporter vectors, shown in FIGURE 8 and FIGURE S1. All vectors feature the 
constitutively active, 643-bp-long GAP promoter, followed by the ACT1 gene totaling 
394 base pairs, made up of a 5’ UTR, and ORFs A and B separated by an intron. The 
ACT1 ORF B is followed by a very short non-coding region (11 bp), which is where the 
xrRNAs were inserted into 1481X, 1481M, 1482X and 1482M vectors. The xrRNA 
element is composed of two adjacent pseudoknot structures totaling 173 bp in length. 
This region is followed by the CrPV IRES element in all the reporter vectors, which is 
192 base pairs long and is immediately followed by the LacZ gene. The LacZ ORF is 
3,066 bp long and was not fully sequenced. The 5’ and 3’ ends of the ORF were 
confirmed by sequencing, but approximately 2,400 bp were left unsequenced. The 
remaining sequence (FIGURE 8) was approximated based on homology and assumed to 
be present due to the confirmed enzymatic activity in the cells expressing the reporters 
(FIGURE 13) and detection of β-galactosidase with protein-specific antibodies (FIGURE 
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12), confirming the presence of the fully-functioning protein. The CUP1-1 ORF (182 bp) 
that follows is in frame with LacZ and is in turn followed by a non-coding region and the 




FIGURE 8. Map of reporter vectors JPS 1481 (top) and 1481X (bottom), 
containing all key features. All reporters contain the following elements, listed in the 
5’3’ direction: the GAP promoter (white arrow), ACT1 (black), CrPV IRES (blue), 
LacZ (magenta), CUP1-1 (brown), and the PGK1 terminator (yellow). In addition, all 
reporters designated as “X” or “M” contain the xrRNAs (red), located between ACT1 and 




The point mutations corresponding to each mutant structure were also confirmed 
by sequencing (FIGURE 8, 9). Each of the two copies of the pseudoknot structure in the 
xrRNAs contains a triplet in which each base was mutated to its corresponding canonical 
Watson-Crick complementary base (AGTTCA), generating the mutant structure 
encoded in JPS 1481M. Similarly, the IRES-dead mutants (1482 and 1482X) contain a 
CCGG mutation toward the end of the structure, which was confirmed by sequencing. 
 
xrRNAs  1481X (1-35)      AGGCAAAACTAACATGAAACAAGGCTAAAAGTCAG 
                1481M (1-35)     AGGCAAAACTAACATGAAACAAGGCTAAATCACAG 
 
               1481X (87-121)   CAAGGACGTTAAAAGAAGTCAGGCCATCACAAATG 
               1481M (87-121)  CAAGGACGTTAAAAGATCACAGGCCATCACAAATG 
 
IRES      1481 (158-192)     AGATTAGGTAGTCGAAAAACCTAAGAAATTTACCT 
               1482 (158-192)     AGATTAGGTAGTCGAAAAACCTAAGAAATTTAGGT 
 
FIGURE 9. Sequence alignments of the different JPS 1480 series reporters 
confirming the presence of point mutations in the mutant structures. The mutant xrRNAs 
contain AGTTCA mutations in bases 30-32 and 103-105 (shown in red, 1481M), and 
the mutant CrPV IRES contains a CCGG mutation in bases 190-191 (shown in blue, 
1482 and 1482X). 
 
3.2 Methionine Initiator tRNA Genes are Knocked-Out in H2545 Strain  
The H2545 laboratory yeast strain was chosen for the investigation of the JPS 
1480 series reporters because it had been previously reported to allow for successful cap-
independent translation (Thompson et al., 2001). The H2545 strain was constructed from 
an ascospore cross between two strains, each containing a mutation that inactivated one 
of the four IMT (methionine initiator tRNA) genes encoded in the WT strain S288C 




two knocked-out IMT genes, imt3 and imt4. Deletion of these two genes limits the 
availability of the eIF2•GTP•Met–tRNAi
Met ternary complex in the cell, therefore 
reducing the rate of cap-dependent translation and allowing the CrPV IRES to effectively 
compete for the translation machinery (Thompson et al., 2001). 
             
FIGURE 10. Colony PCR results confirming that imt3 and imt4 genes are 
knocked-out in H2545 yeast, priming that strain for successful cap-independent 
translation of the bicistronic reporter. Large individual colonies of S288C and H2545 
were resuspended in lysis buffer and lysed by heating to 95 °C. Lysates were used as 
templates for PCR amplification using imt3- and imt4-specific primers and subjected to 
equal reaction conditions. PCR products were analyzed through gel electrophoresis and 
examined for presence of bands at different lengths between the two strains. 
 
In order to experimentally verify that the two initiator methionine genes (imt3 and 
imt4) are knocked-out in the H2545 strain, cells were subjected to colony PCR analysis 
and compared to the reference strain S288C. The genomic DNA of the H2545 and S288C 
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strains was isolated and analyzed via PCR using target-specific primers designed to 
amplify the full imt3 and imt4 ORFs. In the WT reference sequence (S288C), PCR 
amplification with the designed primers leads to products that are 241 and 247 base pairs 
long for imt3 for imt4 respectively. Each imt ORF IS 72 BP long and contains a BssHII 
site at position 21, which was digested and used to create the mutants. The restriction site 
was filled in with deoxynucleotides, then blunt-end ligated to phosphorylated XhoI 
linkers. Similarly, the full TRP1 gene (675 bp long) was obtained by digestion of the 
EcoRI-BssHII fragment (890 bp long), which was also filled with deoxynucleotides and 
blunt-end ligated to phosphorylated XhoI linkers. The two fragments were digested at the 
XhoI site and linked together, resulting in disruption of each imt ORF with the TRP1 gene 
(Byström and Fink, 1989). This leads to mutant cells with inactive imt3 and imt4 genes, 
but a fully-functioning copy of the TRP1 gene. PCR amplification of the knockout 
mutants should result in products with an increased fragment length using the imt3- and 
imt4-specific primers, at 1133 bp and 1139 respectively. The colony PCR experiments 
results confirm that both methionine initiator tRNA genes are knocked out in the H2545 
strain (FIGURE 10). 
 
3.3 Expression of Reporters Containing xrRNAs Yields Decay-Resistant Transcripts 
In order to determine if the addition of xrRNAs to the reporters resulted in the 
accumulation of decay-resistant fragments, RNA was isolated from whole cell lysates and 
subjected to reverse transcription and subsequent fragment analysis by capillary 
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electrophoresis. Fragment analysis of cell cultures with the different JPS 1480 series 
reporters showed the presence of decay-resistant transcripts containing one and two  
 
  
FIGURE 11.  A) Fragment analysis data showing the presence of transcripts 
protected from degradation by one and two copies of the xrRNAs (shown by green box). 
MW size standard shown as orange peaks, and corresponding lengths (bp) of the standard 
peaks are indicated by black arrows B) Expected fragment length of transcripts 
containing the xrRNAs. Total yeast RNA content was isolated and reverse-transcribed 
using a fluorescently-labeled primer. The resulting fluorescently-labeled cDNA 
fragments were analyzed by capillary electrophoresis. The green arrow illustrates the 







copies of the Xrn1-resistant structures, at around 319 and 392 bp respectively, in cells 
expressing the JPS 1481X reporter (FIGURE 11). The decay-resistant transcripts were 
detected only in the cells expressing the reporter containing the fully-functioning xrRNAs 
(red), and not in the mutant (blue), or in the reporter lacking the structure altogether 
(black). These xrRNAs, indicated by the green boxes, appear to accumulate in the cells, 
as evidenced by the height of the xrRNA protected fragments relative to the height of all 





                  











FIGURE 12. Western Blot of H2545 cells expressing three different reporters 
from the JPS 1480 series. Whole cell protein extracts were incubated with either anti-β-
Galactosidase or anti-GAPDH primary antibodies. A prominent band corresponding to 
the molecular weight of β-Galactosidase was observed in the cells expressing the 
reporter containing the fully-functioning xrRNAs (1481X), but no significant bands 
were observed if the reporter was lacking the xrRNAs (1481) or contained the mutant 
copy (1481M). This confirms that addition of the xrRNAs leads to increased protein 
expression of the target protein. 
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FIGURE 13. Enzymatic activity of β-galactosidase in cell cultures expressing 
different reporters from the JPS 1480 series. Total yeast protein lysates were incubated 
with ONPG for 3 hours. Enzymatic activity was quantified as absorbance at 420 nm and 
normalized for reaction time and initial cell concentration, measured as absorbance at 600 
nm. The reporters include either the active form of each element (+), the mutant or 
inactive form (-), or are missing the element listed (left blank). Increased enzymatic 
activity is only observed upon transformation with reporters with fully-functioning copies 
of both xrRNAs and IRES. 
 
 
3.4 Partially-Decayed Messenger RNAs Are Translated and Lead to Enhanced 
Protein Expression. 
Through the use of β-Galactosidase-specific antibodies, results show increased 
protein content in cell cultures (of comparable cell concentrations as measured by optical 
density) containing the decay-resistant structures (FIGURE 12). As seen in Figure 12, the 
most prominent band is observed at the correct molecular weight (116 kD) for β-
Galactosidase only for cells containing the Xrn1-resistant structures. 
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The β-Galactosidase Assay also revealed increased enzymatic activity of the cells 
expressing the reporters containing the fully-functioning xrRNAs and IRES elements. 
After normalization by time and cell concentration (absorbance at 600 nm), as well as 
subtracting the enzymatic activity in wild-type cells, addition of Xrn1-resistant structures 
resulted in approximately 32-fold increase in enzymatic activity (FIGURE 13, TABLE 
S1). Results from the enzymatic activity assay and western blot demonstrate that the 
partially-decayed messenger RNAs are successfully translated in the H2545 cells. 
 
3.5 DXO1 knockouts display increased enzymatic activity after transformation with 
JPS 1480s series reporters 
 CRY1 cells (W303-1A) wild-type cells, as well as knockouts for XRN1, DXO1, 
and XRN1/DXO1 were transformed with the JPS 1480 series reporters 1481, 1481X, and 
1481M. CRY1 cells contain all four IMT genes, suggesting that cap-dependent translation 
in these cells should be favored and internal-ribosomal entry should not be observed. β-
galactosidase assay was performed on all resulting cells, and the results indicated that 
cap-independent translation of the IRES is active in the DXO1 knockout strain, as shown 
by the increased enzymatic activity of β-galactosidase in the cells expressing the 
functioning xrRNAs (FIGURE 14). The DXO1 knockout expressing the JPS 1481X 
reporter was calculated to have an enzymatic activity corresponding to 96.7 Miller Units, 
a significant increase compared to the 1.2 Miller Units calculated for the WT strain 
expressing the same reporter (FIGURE 14), and the 1.4 Miller Units calculated for the 





 FIGURE 14. β-galactosidase activity of WT CRY1 cells and three different 
knockout strains expressing three of the reporters from the JPS 1480 series. Total yeast 
protein lysates were incubated with ONPG for 3 hours. Enzymatic activity was quantified 
as absorbance at 420 nm and normalized for reaction time and initial cell concentration, 
measured as absorbance at 600 nm. β-galactosidase activity of WT CRY1 cells and three 
different knockout strains expressing three of the reporters from the JPS 1480 series. The 
increased enzymatic activity observed in the DXO1 knockout strain suggests that cap-
independent translation of the CrPV IRES element is active in this strain. 
  
 
Surprisingly, the double-knockout cells (∆XRN1/∆DXO1) did not exhibit 
increased β-galactosidase activity. In order to genetically rescue the double-knockout 
strain, cells were transformed with plasmids containing the full XRN1 ORF. Two 




































































































Dharmacon and containing a (-ura) selective marker (Dharmacon product # YSC3869-
202330614). The second plasmid was a gift from Jay R. Hesselberth’s lab and contains a 
(-leu) selective marker (Plasmid BJH 872). Both sets of cells were tested via β-
galactosidase assay but did not demonstrate any increased enzymatic activity compared 
to the empty cells (Figure S3). These results indicate that adding the XRN1 ORF to the 
∆XRN1/∆DXO1 strain does not genetically rescue IRES activity in this strain. 
 
 FIGURE 15. Colony PCR confirmation of ∆XRN1 genotype (xrn1∆::HygMX). 
Large individual colonies of wild-type CRY1 cells, as well as knockouts for XRN1, 
DXO1 and XRN1/DXO1, were resuspended in lysis buffer and lysed by heating to 95 °C. 
Lysates were used as templates for PCR amplification using XRN1-specific primers and 
subjected to equal reaction conditions. PCR products were analyzed through gel 
electrophoresis. The PCR product obtained at around 2200 bp (left) in the ∆XRN1 and 
∆XRN1/∆DXO1 strains confirms that, in these cells, the XRN1 ORF has been replaced 
with the HygMX cassette, yielding the knockout genotype. The PCR product observed at 
around 460 bp in the CRY1 (and ∆DXO1) cells confirms that the wild-type cells contain 




Since genetic rescue of the XRN1/DXO1 knockout strain was unsuccessful, it was 
important to confirm the genotype of the cells, as well as the sequence of the pXRN1 
plasmid. All four strains were subjected to colony PCR analysis using the target specific 
primers listed in TABLE 2.  
 
 FIGURE 16. Colony PCR confirmation of the ∆DXO1 genotype 
(dxo1∆::KanMX). Large individual colonies of wild-type CRY1 cells, as well as 
knockouts for XRN1, DXO1 and XRN1/DXO1, were resuspended in lysis buffer and lysed 
by heating to 95 °C. Lysates were used as templates for PCR amplification using DXO1-
specific primers, subjected to equal reaction conditions, and analyzed through gel 
electrophoresis. The results confirm the WT and mutant genotype, as observed in the 
difference in length between the PCR products observed at around 1980 bp in the CRY1 




Results from the colony PCR experiments confirm that the XRN1 gene is not 
present in the ∆XRN1 and ∆XRN1/∆DXO1 strains, but is present in the WT CRY1 strain 
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and the ∆DXO1 strain (FIGURE 15). Primers A and D (left) land in the adjacent regions 
of the genome to the XRN1 gene and should yield PCR products corresponding to either 
the full XRN1 ORF (plus flanking regions) in the WT cells or the HygMX cassette in the 
knockout cells. The full-length product for the WT cells, expected at a length of 5213 bp, 
was not observed. The resulting PCR product observed in the knockout cells, at around 
2202 bp, corresponds to the expected length and serves as confirmation of the genotype 
of the ∆XRN1cells. The genotype of the WT cells was confirmed by using primer C 
(right), which lands inside the ORF and should therefore only yield a PCR product (460 
bp) in cells that contain the XRN1 ORF. 
Similarly, by using primers that land in the flanking regions of the genome to the 
DXO1 ORF, the difference in lengths between the WT and knockout strains can be 
observed (FIGURE 16). The CRY1 and ∆XRN1 contain the full DXO1 ORF, and 
therefore yield PCR products observed at around 1980 bp. In the knockout strains, the 
DXO1 ORF has been replaced with the KanMX cassette, which is slightly longer, 
resulting in the observed bands at around 2008 bp in the ∆DXO1 and the ∆XRN1/∆DXO1 
strains.  
Sequencing results of the BJH 872 plasmid encoding for pXRN1 should confirm 
that the plasmid encodes for the full-length protein, which should be fully-functioning 
(FIGURE S4, pending last sequencing results).  The fact that the ∆XRN1/∆DXO1 cells 
that were transformed with both the BJH 872 plasmid and the JPS 1480 series plasmids 
(either 1481, 1481X, or 1481M) were capable of growing in SD media lacking both 
uracil and leucine suggests that the cells were expressing both plasmids simultaneously. 
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Since the sequencing results of the BJH 872 plasmid suggest that the plasmid does 
encode the full-length protein, the failure to genetically rescue the double-knockout 








CHAPTER FOUR: DISCUSSION AND SUMMARY 
Xrn1 is the major eukaryotic exonuclease and binds to a 5’ monophosphate 
substrate exposed after removal of the m7G cap by a decapping enzyme (Dcp1 in yeast). 
Xrn1 proceeds in the 5’3’ direction but can be effectively stopped by the pseudoknot 
structures encoded in the 3’UTR of the genome of Flaviviruses (Chapman et al., 2014). 
These Xrn1-resistant structures, named xrRNAs, have potential therapeutic and industrial 
applications, since they can theoretically be used to enhance protein expression of target 
genes by protecting them from degradation. Current usage of recombinant DNA 
technology includes a wide-range of applications in which target proteins and metabolites 
are produced at a large scale in order to improve human health and lifestyle (Khan et al., 
2016). These applications include synthesis of vaccines (Zhang et al., 2011), 
pharmaceuticals (Lomedico, 1982), biofuels (Ullah et al., 2015), alternative energy 
sources (Tiwari and Pandey, 2012), and could have promising uses in the development of 
mRNA therapeutics (Zhong et al., 2018). Using a combination of existing recombinant 
DNA technology with xrRNAs can substantially increase the effectiveness of these and 
many other applications. 
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Our results support the hypothesis that artificially-installed Xrn1-resistant 
structures protect RNA transcripts and lead to increased expression of downstream genes 
(FIGURES 12, 13, 14, S3). The β-galactosidase assay indicates an average 32-fold 
increase in enzymatic activity in cells expressing the decay-resistant structures, compared 
to cells expressing the reporter without the decay-resistant structures (FIGURE 13, 
TABLE S1). Interestingly, there is a small increase in enzymatic activity (1.25x) found 
with the cells expressing the mutant version of the decay-resistant structures, suggesting 
the mutant structures provide a small level of protection from degradation. This effect is 
consistently observed and should be investigated. The IRES-dead mutants (1482 and 
1482X) do not appear to exhibit any increase in enzymatic activity, providing evidence 
that the IRES is indeed inactive and cap-independent translation does not occur. Future 
directions can include analysis of analogous reporters containing a galactose-inducible 
reporter. This should allow for quantification of protein expression over time in order to 
compare the difference in the rate of mRNA decay 
Fragment analysis results showed the build-up of xrRNA-protected transcripts 
containing one and two copies of the viral pseudoknot structure (FIGURE 11). Future 
directions can include detection of the longer RNA transcripts (above 500-600 bp), as 
well as analysis of the IRES-dead mutants (1482 and 1482X). Since the IRES-dead 
mutants contained fully-functioning Xrn1-resistant structures, the length of the transcripts 
detected should be identical to those found in the IRES-active reporters. This should 
provide evidence that, even in the presence of fully-active Xrn1-resistant structures (and 
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therefore an increased concentration of transcripts), increased protein expression is not 
possible without also a fully active IRES. 
H2545 S. cerevisiae cells are ideal for the investigation of reporters including the 
CrPV IRES, since they contain genetic mutations that have been shown to be conducive 
to successful cap-independent translation via internal-ribosomal entry (Thompson et al., 
2001). Our results confirm that IRES-dependent translation is active in these cells 
(FIGURE 13). Our results also show that the two artificially-installed viral structures 
(xrRNAs and CrPV IRES) work in tandem, since the reporters were successfully 
transcribed and translated (FIGURES 11 and 13).  
In order to examine the effect of the deletion of genes XRN1 and DXO1 in the rate 
of cap-independent translation, a different strain was used, whose wild-type cells were 
expected to show no IRES activity. β-galactosidase assay results of the empty wild-type 
CRY1 cells, as well as the empty knockout cells, served as a control and established the 
basal level of enzymatic activity in this strain (FIGURE S3). As expected, after 
transformation with the JPS 1481X reporter, the wild-type CRY1 cells did not show 
increased enzymatic activity when compared to the empty cells, confirming that the 
CrPV structure encoded in the reporter does not successfully initiate translation in the 
wild-type cells. However, when the DXO1 gene is deleted, we saw an average 64-fold 
increase in enzymatic activity (FIGURE S3, 96.7 Miller units) in the cells expressing the 
JPS 1481X reporter when compared to the empty cells (1.2 Miller units in CRY1 cells 
and 1.4 Miller units in DXO1). Therefore, our results show that deletion of DXO1 
changes cellular conditions enough to allow for successful IRES-dependent translation. 
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Thompson et al. reported that the CrPV IRES functioned successfully in cells that had 
lower cellular concentrations of the eIF2•GTP•Met–tRNAi
Met ternary complex, either due 
to the disruption of two initiator tRNAMet genes (cells used in this work), or due to 
constitutive expression of the eIF2 kinase GCN2. Our results indicate that deletion of 
DXO1 also leads to decreased concentrations of the eIF2•GTP•Met–tRNAi
Met ternary 
complex. 
DXO1 is a predominantly cytoplasmic decapping exonuclease found in some 
yeast. This enzyme is involved in mRNA 5’-end-capping quality-control and has 5’3’ 
exonuclease activity. It has 5’ triophosphonucleotide hydrolase activity and preferentially 
decaps transcripts with unmethylated caps. Its exonuclease activity allows it to single-
handedly decap and degrade faulty mRNAs (Chang et al., 2012).  Based on current 
knowledge, disruption of either the decapping or the exonuclease activity of DXO1 
should not decrease the cellular concentration of the eIF2•GTP•Met–tRNAi
Met ternary 
complex. It remains unclear how deletion of the DXO1 gene leads to the ability of the 
knockout cells to successfully initiate translation using the CrPV IRES. Since our results 
suggest that deletion of the DXO1 gene makes cap-dependent translation less favorable, 
and since it has been shown that DXO1 interacts with the 5’ end of an mRNA, it is 
possible that this enzyme plays an additional role in the cell and is somehow involved in 
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  FIGURE S1. Comprehensive map of reporter vectors JPS 1481 (top) and 1481X 
(bottom), containing all key features, restriction enzyme cleavage sites, and primers 
used for sequencing (shown by lime green arrows indicating direction of primer). 




  TABLE S1. Quantitative results of β-galactosidase assay of H2545 cells 
expressing different JPS 1480 series reporters. Total yeast protein lysates were 
incubated with ONPG for 3 hours. Enzymatic activity was quantified as absorbance 
at 420 nm and normalized for reaction time and initial cell concentration, measured 





  FIGURE S2. Qualitative results of β-galactosidase assay of H2545 cells 
expressing different. The tubes, listed from left-to-right, belong to cells expressing 
the following JPS 1480 series reporters: 1481, 1481X, 1481M, 1482, 1482X, and 
empty cells. As results indicate, cells containing the IRES-dead elements have close 
to the same enzymatic activity as the empty cells (1482, 1482X). The cells 
containing the functioning IRES but inactive xrRNAs have some increased activity, 
as evidenced by the light yellow color (1481, 1481M). The cells with the highest 
activity are those in which both elements are active (1481X, second tube from the 
left). 
30-Aug 31-Aug 8-Sept (1) 8-Sept (2) Mean St Dev
JPS 1481 4.37 6.55 3.20 3.03 4 2
JPS 1481 X 124.33 155.67 102.00 128.66 128 22
JPS 1481 M 3.95 6.56 4.57 5.10 5 1
JPS 1482 3.05 6.07 2.31 2.89 4 2





 FIGURE S3. β-galactosidase activity of WT CRY1 cells and three different 
knockout strains expressing three of the reporters from the JPS 1480 series, and the 
double-knockout strains also expressing two different plasmids containing the XRN1 
ORF. Only the DXO1 knockout appears to have increased enzymatic activity when 
compared to the empty cells, suggesting that adding the XRN1 ORF to the double-
knockout strain does not genetically rescue IRES activity. The activity of empty cells was 









FIGURE S4. Sequencing map of BJH 872 plasmid, encoding pXRN1. Map shows 
entire length of yeast wild-type XRN1gene (black line). Colored arrows indicate fragment 
that was sequenced using each corresponding primer, as well as direction of the primer. 
